Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001019687-15-001463
Filing Date
2015-04-15
Accepted
2015-04-15 16:44:09
Documents
38
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT vgls_10k-123114.htm 10-K 1895260
2 WARRANT TO PURCHASE STOCK vgls_ex402.htm EX-4.2 35775
3 WARRANT TO PURCHASE STOCK vgls_ex403.htm EX-4.3 36331
4 WARRANT TO PURCHASE STOCK vgls_ex404.htm EX-4.4 42020
5 WARRANT TO PURCHASE STOCK vgls_ex405.htm EX-4.5 37695
6 WARRANT TO PURCHASE STOCK vgls_ex406.htm EX-4.6 37052
7 WARRANT TO PURCHASE STOCK vgls_ex407.htm EX-4.7 32333
8 WARRANT TO PURCHASE STOCK vgls_ex408.htm EX-4.8 36939
9 CONVERTIBLE PROMISSORY NOTE vgls_ex10156.htm EX-10.156 37715
10 CONVERTIBLE PROMISSORY NOTE vgls_ex10157.htm EX-10.157 42730
11 CONVERTIBLE PROMISSORY NOTE AND WARRANT PURCHASE AGREEMENT vgls_ex10158.htm EX-10.158 152008
12 CONVERTIBLE PROMISSORY NOTE vgls_ex10159.htm EX-10.159 54584
13 SUBSCRIPTION AGREEMENT vgls_ex10160.htm EX-10.160 27997
14 SERVICES AGREEMENT vgls_ex10161.htm EX-10.161 28876
15 CONVERTIBLE DEBENTURE vgls_ex10162.htm EX-10.162 48235
16 CONVERTIBLE DEBENTURE vgls_ex10163.htm EX-10.163 51305
17 CONVERTIBLE PROMISSORY NOTE AND WARRANT PURCHASE AGREEMENT vgls_ex10164.htm EX-10.164 121583
18 CONVERTIBLE PROMISSORY NOTE vgls_ex10165.htm EX-10.165 37021
19 CONVERTIBLE PROMISSORY NOTE vgls_ex10166.htm EX-10.166 37788
20 CONVERTIBLE PROMISSORY NOTE AND WARRANT PURCHASE AGREEMENT vgls_ex10167.htm EX-10.167 122230
21 CONVERTIBLE DEBENTURE vgls_ex10168.htm EX-10.168 45604
22 CONVERTIBLE PROMISSORY NOTE AND WARRANT PURCHASE AGREEMENT vgls_ex10169.htm EX-10.169 112178
23 CONVERTIBLE PROMISSORY NOTE vgls_ex10170.htm EX-10.172 36172
24 CONVERTIBLE DEBENTURE AND WARRANT PURCHASE AGREEMENT vgls_ex10171.htm EX-10.171 128268
25 CONVERTIBLE DEBENTURE vgls_ex10172.htm EX-10.172 38188
26 UNSECURED REVOLVING CREDIT NOTE vgls_ex10173.htm EX-10.173 75976
27 CODE OF ETHICS vgls_ex1401.htm EX-14.1 36974
28 SUBSIDIARIES OF REGISTRANT vgls_ex2101.htm EX-21.1 2574
29 CONSENT vgls_ex2301.htm EX-23.1 1642
30 CERTIFICATION vgls_ex3101.htm EX-31.1 7933
31 CERTIFICATION vgls_ex3102.htm EX-31.2 7769
32 CERTIFICATION vgls_ex3201.htm EX-32.1 3148
  Complete submission text file 0001019687-15-001463.txt   7225894

Data Files

Seq Description Document Type Size
33 XBRL INSTANCE FILE vgls-20141231.xml EX-101.INS 605027
34 XBRL SCHEMA FILE vgls-20141231.xsd EX-101.SCH 40533
35 XBRL CALCULATION FILE vgls-20141231_cal.xml EX-101.CAL 61839
36 XBRL DEFINITION FILE vgls-20141231_def.xml EX-101.DEF 94271
37 XBRL LABEL FILE vgls-20141231_lab.xml EX-101.LAB 277752
38 XBRL PRESENTATION FILE vgls-20141231_pre.xml EX-101.PRE 210428
Mailing Address 121 GRAY AVENUE, SUITE 200 SANTA BARBARA CA 93101
Business Address 121 GRAY AVENUE, SUITE 200 SANTA BARBARA CA 93101 805-879-9000
VG Life Sciences Inc. (Filer) CIK: 0001091326 (see all company filings)

EIN.: 330814123 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26875 | Film No.: 15772129
SIC: 2834 Pharmaceutical Preparations